Coley C M, Li Y H, Medsger A R, Marrie T J, Fine M J, Kapoor W N, Lave J R, Detsky A S, Weinstein M C, Singer D E
Medical Practices Evaluation Center, Massachusetts General Hospital, Boston, USA.
Arch Intern Med. 1996 Jul 22;156(14):1565-71.
To measure preferences for initial outpatient vs hospital care among low-risk patients who were being actively treated for community-acquired pneumonia (CAP).
Study patients included 159 patients with CAP, 57 (36%) initially hospitalized, who were identified as being at low risk for early mortality using a validated prediction model. Subjects were enrolled from university and community health care facilities located in Boston, Mass, Halifax, Nova Scotia, and Pittsburgh, Pa, participating in the Pneumonia Patient Outcome Research Team prospective cohort study of CAP. Three utility assessment techniques (category scaling, standard gamble, and willingness to pay) were used to measure the strength of patient preferences for the site of care for low-risk CAP. At the time of initial therapy or during the early recuperative period, patient preferences were assessed across a spectrum of potential clinical outcomes using 7 standardized pneumonia clinical vignettes.
Responses to the 7 pneumonia scenarios indicated that most patients consistently preferred outpatient-based therapy. This pattern was observed regardless of whether patients had actually been treated initially at home or in a hospital. Patients (74%) who stated that they generally preferred home care for low-risk CAP were willing to pay a mean of 24% of 1 month's household income to be assured of this preference. Preference for home care, as measured by the category scaling and the willingness to pay, persisted after adjustment for sociodemographic and baseline health status covariates. Sixty nine percent of interviewed patients said that their physician alone determined whether they would be treated in the hospital or at home. Only 11% recalled being asked if they had a preference for either site of care.
Most patients, even those treated initially in a hospital, who were at low risk for mortality from CAP prefer outpatient treatment. However, most physicians appear not to involve patients in the site-of-care decision. More explicit discussion of patient preferences for the location of care would likely yield more highly valued care by patients as well as less costly treatment for CAP.
衡量正在接受社区获得性肺炎(CAP)积极治疗的低风险患者对初始门诊治疗与住院治疗的偏好。
研究患者包括159例CAP患者,其中57例(36%)最初住院,这些患者使用经过验证的预测模型被确定为早期死亡低风险患者。研究对象来自位于马萨诸塞州波士顿、新斯科舍省哈利法克斯和宾夕法尼亚州匹兹堡的大学和社区医疗保健机构,参与了肺炎患者结局研究团队对CAP的前瞻性队列研究。使用三种效用评估技术(类别量表、标准博弈和支付意愿)来衡量低风险CAP患者对治疗地点的偏好强度。在初始治疗时或早期康复期间,使用7个标准化的肺炎临床案例,针对一系列潜在临床结局评估患者偏好。
对7个肺炎案例的回答表明,大多数患者始终更倾向于门诊治疗。无论患者最初实际是在家中还是在医院接受治疗,均观察到这种模式。表示总体上更倾向于低风险CAP家庭治疗的患者(74%)愿意平均支付1个月家庭收入的24%以确保这种偏好。在对社会人口统计学和基线健康状况协变量进行调整后,通过类别量表和支付意愿衡量的对家庭治疗的偏好依然存在。69%的受访患者表示,只有医生决定他们是在医院还是在家中接受治疗。只有11%的患者回忆起被询问是否对治疗地点有偏好。
大多数患者,即使是那些最初在医院接受治疗的患者,其CAP死亡风险较低,他们更倾向于门诊治疗。然而,大多数医生似乎并未让患者参与治疗地点的决策。更明确地讨论患者对治疗地点的偏好可能会使患者获得更有价值的治疗,同时降低CAP的治疗成本。